Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site Elaheh NasrollahzadehSepideh RaziNima Rezaei Review 04 June 2020 Pages: 1673 - 1697
IL-12 regulates the expansion, phenotype, and function of murine NK cells activated by IL-15 and IL-18 Naoto OkaTzvetanka MarkovaHaruki Okamura Original Article 24 April 2020 Pages: 1699 - 1712
Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study Lujun ShenHan QiWeijun Fan Original Article Open access 24 April 2020 Pages: 1713 - 1724
Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model Manjarika DeSneha GhoshNahid Ali Original Article 24 April 2020 Pages: 1725 - 1735
Peri-tumor administration of controlled release anti-CTLA-4 synergizes with systemic anti-PD-1 to induce systemic antitumor immunity while sparing autoimmune toxicity Airi HaruiSandra M. McLachlanMichael D. Roth Original Article 24 April 2020 Pages: 1737 - 1749
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy Lukas MarcelisAsier AntoranzThomas Tousseyn Original Article 25 April 2020 Pages: 1751 - 1766
Patients’ NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing Assila BelounisMarina AyoubMichel Duval Original Article 27 April 2020 Pages: 1767 - 1779
Anti-angiogenesis therapy overcomes the innate resistance to PD-1/PD-L1 blockade in VEGFA-overexpressed mouse tumor models Qiaohong WangJingze GaoXia Wu Original Article 28 April 2020 Pages: 1781 - 1799
Blockade of CD73 delays glioblastoma growth by modulating the immune environment J. H. AzambujaR. S. SchuhE. Braganhol Original Article 29 April 2020 Pages: 1801 - 1812
Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors Lihong PengYong WangYong Li Original Article Open access 29 April 2020 Pages: 1813 - 1822
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature Tsubasa WatanabeElke FiratGabriele Niedermann Original Article Open access 29 April 2020 Pages: 1823 - 1832
Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR) Mir Hadi JazayeriTayebe AghaieHamid Nickho Original Article 30 April 2020 Pages: 1833 - 1840
Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue Koushan Sineh SepehrAlireza RazaviSeyed Mahmoud Hashemi Original Article 30 April 2020 Pages: 1841 - 1854
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer Tao WangQuan ZhouJiejie Xu Original Article 04 May 2020 Pages: 1855 - 1867
Cysteine cathepsins L and X differentially modulate interactions between myeloid-derived suppressor cells and tumor cells Tanja JakošAnja PišlarJanko Kos Original Article 05 May 2020 Pages: 1869 - 1880
A gene expression-based immune signature for lung adenocarcinoma prognosis Lijuan WangXizhi LuoFeifei Xiao Original Article 05 May 2020 Pages: 1881 - 1890
Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells Yihe YanLeting ZhengDavid A. Geller Original Article 06 May 2020 Pages: 1891 - 1903
Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone Jasna MetovicLaura AnnaratoneMauro Papotti Original Article 06 May 2020 Pages: 1905 - 1916
Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma Mehdi DehghaniMehdi KalaniNargess Arandi Original Article 08 May 2020 Pages: 1917 - 1928
Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors Ayumi HashimotoTakeshi FukumotoDmitry Gabrilovich Research Report 20 May 2020 Pages: 1929 - 1936
Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy Melissa J. DaneshPatrick M. MulvaneyChrysalyne D. Schmults Letter to the Editors 25 June 2020 Pages: 1937 - 1941